Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$123.8 - $132.96 $164,901 - $177,102
-1,332 Reduced 8.5%
14,336 $1.83 Billion
Q1 2024

Apr 10, 2024

SELL
$113.24 - $131.95 $12,796 - $14,910
-113 Reduced 0.72%
15,668 $2.04 Billion
Q4 2023

Jan 05, 2024

BUY
$100.18 - $109.02 $1.58 Million - $1.72 Million
15,781 New
15,781 $1.72 Billion
Q2 2023

Jul 06, 2023

SELL
$108.61 - $118.38 $369,708 - $402,965
-3,404 Reduced 19.1%
14,422 $1.66 Billion
Q1 2023

Apr 05, 2023

BUY
$102.94 - $114.86 $96,557 - $107,738
938 Added 5.55%
17,826 $1.9 Billion
Q4 2022

Feb 16, 2023

BUY
$87.44 - $112.11 $1.48 Million - $1.89 Million
16,888 New
16,888 $1.87 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track St. Louis Financial Planners Asset Management, LLC Portfolio

Follow St. Louis Financial Planners Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of St. Louis Financial Planners Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on St. Louis Financial Planners Asset Management, LLC with notifications on news.